Page values for "Empagliflozin"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Empagliflozin |
| brand | String | Jardiance |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:SGLT2_inhibitors|SGLT2 inhibitor]] • [[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]] • [[:Category:Heart_failure_medications|Heart failure medication]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000278-QINU`"', '"`UNIQ--vote-00000279-QINU`"', '"`UNIQ--vote-0000027A-QINU`"', '"`UNIQ--vote-0000027B-QINU`"' |
| starting_dose | String | 10 mg PO once daily in the morning; may titrate to 25 mg for additional glycemic effect |
| preparations | String | 10 mg, 25 mg tablets |
| fda_max | String | 25 mg/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Glycosuria within hours; HbA1c effect at 12 weeks; cardiovascular and renal benefits over months |
| duration | String | 24 hours |
| halflife | String | ~12.4 hours'"`UNIQ--ref-0000027C-QINU`"' |
| bioavailability | String | High (oral; not affected by food, but typically given with the morning meal)'"`UNIQ--ref-0000027D-QINU`"' |
| pregnancy | String | Avoid in second and third trimesters; fetal SGLT2 inhibition disrupts kidney development.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |